Innovation

Advances in Precision-based Nano Technology Targeting Neurological Disease


https---cdn.evbuc.com-images-37174878-232131716630-1-original
Monday, November 20, 2017 | 6:00 - 8:45 PM Add to Calendar

Join Vyripharm Biopharmaceuticals for a group of lectures surrounding the application of nanotheranostic technology in the evaluation of integrated medicine in neurological disease and cancer, as well as the role of the human endocannabinoid system in neuroinflammation, neurodegeneration and neuroelectrical pathology.

Those will be followed by discussions from others in the biosciences industry and a panel discussion and Q&A.

Lecturers include:

  • Elias Jackson, Ph.D., director of scientific public relations for Vyripharm
  • HJ Raza, M.D., Ph.D, chief medical officer of C3 Global Biosciences
  • Andrew Serafini, CEO of C3 Global Biosciences
  • Tracy Ryan, CEO of CannaKids.org

 


Location

TMC Innovation Institute

2450 Holcombe Blvd., Suite X, Houston, TX 77021

Contact

Gretchen Mazziotti

713-357-1043